Citi Discount Zert 0QF 25.09.2024/ DE000KH76DD7 /
25/06/2024 21:50:11 | Chg.- | Bid22:00:40 | Ask22:00:40 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
98.89EUR | - | - Bid Size: - |
- Ask Size: - |
MODERNA INC. DL-... | - - | 25/09/2024 | Call |
GlobeNewswire
18/06
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire
13/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
05/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
22/05
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
12/05
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
08/05
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
01/05
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...